Literature DB >> 21221512

The molecular pathogenesis of HIV-1 associated nephropathy: recent advances.

Natalia Papeta1, Roel Sterken, Krzysztof Kiryluk, Robert Kalyesubula, Ali G Gharavi.   

Abstract

HIV-1-associated nephropathy (HIVAN) is a major complication of HIV-1 infection, frequently resulting in kidney failure. HIVAN arises due to HIV-1-induced dysregulation of podocytes, the glomerular epithelial cells that establish and maintain the kidney filtration barrier. Host genetic factors are important for the development of HIVAN. The risk of HIVAN is greatest in populations of African ancestry, and is attributable to a genetic variation at the APOL1 locus on chromosome 22. Mouse models of HIVAN enable delineation of dysregulated pathways underlying disease. Identification of HIVAN susceptibility loci in a mouse model, combined with expression quantitative trait locus mapping, has demonstrated that murine HIVAN loci transregulate podocyte gene expression. HIV-1 induces perturbations in podocyte expression response, suggesting that HIV-1 potentially interferes with compensatory pathways that normally restore cellular homeostasis in the face of genetic mutations. These findings present a framework for identification of podocyte transregulators and reconstruction of the molecular networks connecting susceptibility genes to the development of nephropathy.

Entities:  

Mesh:

Year:  2011        PMID: 21221512     DOI: 10.1007/s00109-010-0719-x

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  67 in total

1.  Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection.

Authors:  J A Winston; L A Bruggeman; M D Ross; J Jacobson; L Ross; V D D'Agati; P E Klotman; M E Klotman
Journal:  N Engl J Med       Date:  2001-06-28       Impact factor: 91.245

2.  Revealing modularity and organization in the yeast molecular network by integrated analysis of highly heterogeneous genomewide data.

Authors:  Amos Tanay; Roded Sharan; Martin Kupiec; Ron Shamir
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

3.  An integrative genomics approach to infer causal associations between gene expression and disease.

Authors:  Eric E Schadt; John Lamb; Xia Yang; Jun Zhu; Steve Edwards; Debraj Guhathakurta; Solveig K Sieberts; Stephanie Monks; Marc Reitman; Chunsheng Zhang; Pek Yee Lum; Amy Leonardson; Rolf Thieringer; Joseph M Metzger; Liming Yang; John Castle; Haoyuan Zhu; Shera F Kash; Thomas A Drake; Alan Sachs; Aldons J Lusis
Journal:  Nat Genet       Date:  2005-06-19       Impact factor: 38.330

4.  Renal epithelium is a previously unrecognized site of HIV-1 infection.

Authors:  Leslie A Bruggeman; Michael D Ross; Nozomu Tanji; Andrea Cara; Steven Dikman; Ronald E Gordon; Godfrey C Burns; Vivette D D'Agati; Jonathan A Winston; Mary E Klotman; Paul E Klotman
Journal:  J Am Soc Nephrol       Date:  2000-11       Impact factor: 10.121

5.  Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients.

Authors:  V Shahinian; S Rajaraman; M Borucki; J Grady; W M Hollander; T S Ahuja
Journal:  Am J Kidney Dis       Date:  2000-05       Impact factor: 8.860

6.  HIVAN phenotype: consequence of epithelial mesenchymal transdifferentiation.

Authors:  Anju Yadav; Sridevi Vallabu; Dileep Kumar; Guohua Ding; Douglas N Charney; Praveen N Chander; Pravin C Singhal
Journal:  Am J Physiol Renal Physiol       Date:  2009-12-16

Review 7.  Controversies in the pathogenesis of HIV-associated renal diseases.

Authors:  Leslie A Bruggeman; Peter J Nelson
Journal:  Nat Rev Nephrol       Date:  2009-10       Impact factor: 28.314

8.  The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy.

Authors:  Christina M Wyatt; Susan Morgello; Rebecca Katz-Malamed; Catherine Wei; Mary E Klotman; Paul E Klotman; Vivette D D'Agati
Journal:  Kidney Int       Date:  2008-12-03       Impact factor: 10.612

9.  Accelerated development of collapsing glomerulopathy in mice congenic for the HIVAN1 locus.

Authors:  Ka T Chan; Natalia Papeta; Jeremiah Martino; Zongyu Zheng; Rachelle Z Frankel; Paul E Klotman; Vivette D D'Agati; Richard P Lifton; Ali G Gharavi
Journal:  Kidney Int       Date:  2008-12-17       Impact factor: 10.612

10.  Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease.

Authors:  Norbert Hubner; Caroline A Wallace; Heike Zimdahl; Enrico Petretto; Herbert Schulz; Fiona Maciver; Michael Mueller; Oliver Hummel; Jan Monti; Vaclav Zidek; Alena Musilova; Vladimir Kren; Helen Causton; Laurence Game; Gabriele Born; Sabine Schmidt; Anita Müller; Stuart A Cook; Theodore W Kurtz; John Whittaker; Michal Pravenec; Timothy J Aitman
Journal:  Nat Genet       Date:  2005-02-13       Impact factor: 38.330

View more
  10 in total

1.  Nef interaction with actin compromises human podocyte actin cytoskeletal integrity.

Authors:  Raymond Tan; Hitesh Patni; Pranai Tandon; Liming Luan; Bipin Sharma; Divya Salhan; Moin A Saleem; Peter W Mathieson; Ashwani Malhotra; Mohammad Husain; Poornima Upadhya; Pravin C Singhal
Journal:  Exp Mol Pathol       Date:  2012-06-18       Impact factor: 3.362

Review 2.  Renal dysfunction in the setting of HIV/AIDS.

Authors:  Jose M Miro; Federico Cofan; Joan C Trullas; Christian Manzardo; Carlos Cervera; Montserrat Tuset; Federico Oppenheimer; Mercedes Brunet; Asuncion Moreno; Josep M Campistol; Jose M Gatell
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

3.  APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease.

Authors:  Derek M Fine; Walter G Wasser; Michelle M Estrella; Mohamed G Atta; Michael Kuperman; Revital Shemer; Arun Rajasekaran; Shay Tzur; Lorraine C Racusen; Karl Skorecki
Journal:  J Am Soc Nephrol       Date:  2011-12-01       Impact factor: 10.121

4.  Hyperglycemia enhances kidney cell injury in HIVAN through down-regulation of vitamin D receptors.

Authors:  Partab Rai; Tejinder Singh; Rivka Lederman; Amrita Chawla; Dileep Kumar; Kang Cheng; Gautam Valecha; Peter W Mathieson; Moin A Saleem; Ashwani Malhotra; Pravin C Singhal
Journal:  Cell Signal       Date:  2014-12-24       Impact factor: 4.315

5.  APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy.

Authors:  Natalia Papeta; Krzysztof Kiryluk; Ami Patel; Roel Sterken; Nilgun Kacak; Holly J Snyder; Phil H Imus; Anand N Mhatre; Anil K Lawani; Bruce A Julian; Robert J Wyatt; Jan Novak; Christina M Wyatt; Michael J Ross; Jonathan A Winston; Mary E Klotman; David J Cohen; Gerald B Appel; Vivette D D'Agati; Paul E Klotman; Ali G Gharavi
Journal:  J Am Soc Nephrol       Date:  2011-10-13       Impact factor: 10.121

6.  Inhibition of Notch pathway attenuates the progression of human immunodeficiency virus-associated nephropathy.

Authors:  Madhulika Sharma; Lynn K Magenheimer; Trisha Home; Karen N Tamano; Pravin C Singhal; Deborah P Hyink; Paul E Klotman; Gregory B Vanden Heuvel; Timothy A Fields
Journal:  Am J Physiol Renal Physiol       Date:  2013-02-06

Review 7.  Human apolipoprotein L1 (ApoL1) in cancer and chronic kidney disease.

Authors:  Chien-An A Hu; Edward I Klopfer; Patricio E Ray
Journal:  FEBS Lett       Date:  2012-03-08       Impact factor: 4.124

8.  Sirolimus modulates HIVAN phenotype through inhibition of epithelial mesenchymal transition.

Authors:  Anju Yadav; Dileep Kumar; Divya Salhan; Rungwasee Rattanavich; Subani Maheshwari; Madhuri Adabala; Guohua Ding; Pravin C Singhal
Journal:  Exp Mol Pathol       Date:  2012-05-02       Impact factor: 3.362

9.  Notch4 activation aggravates NF-κB-mediated inflammation in HIV-1-associated nephropathy.

Authors:  Rajni Vaid Puri; Sireesha Yerrathota; Trisha Home; Jessica Y Idowu; V Praveen Chakravarthi; Christopher J Ward; Pravin C Singhal; Gregory B Vanden Heuvel; Timothy A Fields; Madhulika Sharma
Journal:  Dis Model Mech       Date:  2019-12-17       Impact factor: 5.758

Review 10.  Human immunodeficiency virus-1 (HIV-1)-mediated apoptosis: new therapeutic targets.

Authors:  Zukile Mbita; Rodney Hull; Zodwa Dlamini
Journal:  Viruses       Date:  2014-08-19       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.